Cargando…
Cell and Tissue Therapy for the Treatment of Chronic Liver Disease
Liver disease is an important clinical problem, impacting 600 million people worldwide. It is the 11th-leading cause of death in the world. Despite constant improvement in treatment and diagnostics, the aging population and accumulated risk factors led to increased morbidity due to nonalcoholic fatt...
Autores principales: | Bram, Yaron, Nguyen, Duc-Huy T., Gupta, Vikas, Park, Jiwoon, Richardson, Chanel, Chandar, Vasuretha, Schwartz, Robert E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864721/ https://www.ncbi.nlm.nih.gov/pubmed/33974812 http://dx.doi.org/10.1146/annurev-bioeng-112619-044026 |
Ejemplares similares
-
Molecular clones of genetically distinct hepatitis B virus genotypes reveal distinct host and drug treatment responses
por: Liu, Yongzhen, et al.
Publicado: (2022) -
Peptide-based scaffolds for the culture and maintenance of primary human hepatocytes
por: MacPherson, Douglas, et al.
Publicado: (2021) -
SARS-CoV-2 Ion Channel ORF3a Enables TMEM16F-Dependent Phosphatidylserine Externalization to Augment Procoagulant Activity of the Tenase and Prothrombinase Complexes
por: Ludington, Jacob G, et al.
Publicado: (2021) -
Targeted viral adaptation generates a simian-tropic hepatitis B virus that infects marmoset cells
por: Liu, Yongzhen, et al.
Publicado: (2023) -
Dual-Reporter
System for Real-Time Monitoring of SARS-CoV-2
Main Protease Activity in Live Cells Enables Identification of
an Allosteric Inhibition Path
por: Bram, Yaron, et al.
Publicado: (2022)